In a blockbuster deal that may reshape the eye care
landscape, Canadian drugmaker Valeant Pharmaceuticals
International Inc. announced it will acquire Bausch + Lomb
for $8.7 billion in cash.
Under the terms of the agreement, Valeant will pay
about $4….
Marguerite McDonald, MD, was recently recognized
for her accomplishments in ophthalmology by CNN.
Her career and landmark contributions were profiled
in the Life’s Work series, which features “innovators
and pioneers who are making a difference in the
world of medicine.”
Specific milestones highlighted by CNN …
Pretreatment with a femtosecond laser significantly
reduced effective phacoemulsification time (EPT),
according to a study in emOphthalmology/em.sup1/sup
The prospective, interventional, consecutive casecontrolled
study included 201 eyes that underwen…
Enrollment has begun in the confirmatory phase 3
clinical trial of BromSite (ISV-303; InSite Vision Inc.) for
the reduction of inflammation and pain after cataract
surgery.
ISV-303 combines a low dose (0.075%) of the nonsteroidal
antiinflammatory drug bromfenac with
InSite’s DuraSite drug delivery technology. This…
The causes of laser-related programming errors in
refractive surgery are likely avoidable if preventive
measures such as strict adherence to patients’ verification
protocol or rigorous rechecking of treatment
parameters are implemented, according to a study in
the emJournal of Refractive Surgery/em.sup1/sup
In a m…
Corneal collagen cross-linking (CXL) stabilized the
progression of ectatic disease 4 years postoperatively
in all age groups and improved the functional and
morphological parameters in select groups, with the
best results in patients between 18 and 39 …
The Trulign Toric PCIOL (Bausch + Lomb), the first
toric IOL that provides astigmatic correction and
improved uncorrected near, intermediate, and distance
vision, has received FDA approval.
The FDA-approved indication of the Trulign is for
“primary implantation in the capsular bag of the eye
for the visual correct…
Avedro, Inc., announced that, in preparation for its
US clinical trial, a select group of refractive surgeons
have completed training in the Lasik Xtra procedure
under Gustavo Tamayo, MD, at the Bogotá Laser
Center in Colombia.
The group of refractive surgeons who underwent
training with Dr. Tamayo included Peter H…
LASIK for high hyperopia using optimized aspheric
profiles is an effective and predictable procedure
but requires further improvement in terms of safety,
according to a study in the emJournal of Cataract and
Refractive Surgery/em.sup1/sup
Fifty-one ey…
The Healon Duet Dual Pack (Abbott Medical Optics
Inc.) ophthalmic viscosurgical device (OVD) is now
available in the United States, according to a company
news release.
The dual pack delivers Abbott’s Healon (sodium
hyaluronate 1%) and Healon EndoCoat (sodium hyaluronate
3%) OVDs in separate sterile trays within
…
Beaver-Visitec International launched the Osher
ThermoDot Marker as part of its wet-field product line,
according to a company news release.
Developed with cataract surgeon Robert H.
Osher, MD, the Osher ThermoDot Marker aims to improve the marking re…
Shire US Holdings, Inc., has acquired SARcode
Bioscience, Inc., according to a company news release.
Under the terms of the agreement, Shire will make an
upfront payment of $160 million, and SARcode shareholders
will be eligible to receive additional u…
Using the calibrated force gauge to test the integrity
of clear corneal wounds in the immediate postoperative
period after cataract surgery proved useful in
examining the propensity for wound leaks, according to
a study in the emJournal of Cataract and…
AcuFocus, Inc., has submitted the final module of the
premarket approval application for the Kamra corneal
inlay to the FDA, according to a company news release.
The Kamra is the first corneal inlay for the treatment of
presbyopia submitted for approva…
The use of topical cyclosporine A emulsion had no
discernable benefit when used for 12 weeks after PRK
or LASIK, according to a study in the Journal of Cataract
and Refractive Surgery.sup1/sup
Patients who underwent PRK (n = 70) or LASIK
(n = 54) were…
Enrollment has been completed for the COMPASS
clinical study evaluating the CyPass Micro-Stent
(Transcend Medical, Inc.) in combination with cataract
surgery for patients with primary open-angle glaucoma,
according to a news release. “This is an important
milestone in the field of glaucoma,” Steven Vold, MD,
found…
BromSite (ISV-303; InSite Vision Inc.) achieved statistically
significant superiority compared with DuraSite
(InSite Vision Inc.) alone in alleviating ocular pain and
inflammation after cataract surgery in a phase 3 clinical
trial, according to a compa…
Although a microwave thermokeratoplasty procedure
reduced myopia and improved postoperative uncorrected
distance visual acuity 1 month postoperatively without
significant side effects, early and complete regression
occurred, according to a study in the…
ReVision Optics, Inc., has received conditional approval
from the FDA to continue and complete enrollment in its
phase 3 clinical trial of the Raindrop Near Vision Inlay (formerly
the PresbyLens), according to a news release. The
prospective, multicent…
The Victus Femtosecond Laser Platform (Bausch + Lomb
Technolas) has received 510(k) clearance from the FDA for
the creation of penetrating arcuate incisions in the cornea
in patients undergoing cataract surgery or other ophthalmic
treatments requiring …